KR870002845A - 식욕조절 및 위암억제용 조성물 - Google Patents

식욕조절 및 위암억제용 조성물 Download PDF

Info

Publication number
KR870002845A
KR870002845A KR1019860008126A KR860008126A KR870002845A KR 870002845 A KR870002845 A KR 870002845A KR 1019860008126 A KR1019860008126 A KR 1019860008126A KR 860008126 A KR860008126 A KR 860008126A KR 870002845 A KR870002845 A KR 870002845A
Authority
KR
South Korea
Prior art keywords
composition
content
appetite control
chitin
chitosan
Prior art date
Application number
KR1019860008126A
Other languages
English (en)
Inventor
페토우 안토니오
Original Assignee
원본미기재
크리노스 인더스트리아 화마코비오로지카 쏘시에떼 퍼 아찌오니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 크리노스 인더스트리아 화마코비오로지카 쏘시에떼 퍼 아찌오니 filed Critical 원본미기재
Publication of KR870002845A publication Critical patent/KR870002845A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Bag Frames (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

내용 없음

Description

식욕조절 및 위암억제용 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (5)

  1. 식이요법 및 약학용 경구조성물로서, 플리아미노사카리드 및 소이 사포닌(so
    y saponin)을 포함하는 것을 특징으로 하며, 전술한 폴리아미노사카리드는 키틴, 키토산 및 이들의 약학적으로 허용되는 염으로부터 선택하는 경구용 조성물.
  2. 제1항에 있어서, 항위염 및 식욕조절 활성도를 가지는 조성물.
  3. 제2항에 있어서, 전술한 폴리아미노사카리드의 일일투여량이 2내지 5g 사이가 되고, 진술한 소이 사포닌의 일일투여량은 5내지 8mg이 되는 것을 특징으로 하는 조성물.
  4. 제1항에 있어서, 통상적인 부형제 및 기초제를 포함하는 정제 또는 캡슐(capsule)의 형태로 되고 여기서 키틴 또는 키토산의 함량이 350내지 700mg이고 소이 사포닌의 함량이 5내지 16mg가 되는 것을 특징으로 하는 조성물.
  5. 제1항에 있어서, 통상적인 부형제 및 기초제을 포함하는 경구용의 겔 형태로 되고, 키틴 또는 키토산의 함량이 8내지 12중량%이고 소이 사포닌의 함량이 0.2내지 0.5중량%인 것을 특징으로 하는 조성물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019860008126A 1985-09-26 1986-09-26 식욕조절 및 위암억제용 조성물 KR870002845A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8522284A IT1207504B (it) 1985-09-26 1985-09-26 Composizione moderatrice dell'appetito ed antigastrica.
IT22284A/85 1985-09-26

Publications (1)

Publication Number Publication Date
KR870002845A true KR870002845A (ko) 1987-04-13

Family

ID=11194158

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860008126A KR870002845A (ko) 1985-09-26 1986-09-26 식욕조절 및 위암억제용 조성물

Country Status (9)

Country Link
US (1) US4999341A (ko)
EP (1) EP0219156B1 (ko)
JP (1) JPS62123122A (ko)
KR (1) KR870002845A (ko)
AT (1) ATE58639T1 (ko)
AU (1) AU596119B2 (ko)
CA (1) CA1273874A (ko)
DE (1) DE3675876D1 (ko)
IT (1) IT1207504B (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030056753A (ko) * 2001-12-28 2003-07-04 주식회사 렉스진바이오텍 표고버섯 균사체, 아가리쿠스 균사체, 수용산키토산을함유하는 비만조절용 건강식품조성물

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229754B (it) * 1989-05-17 1991-09-10 Farmhispania Procedimento per la preparazione del chitosano e di suoi derivati contenenti gruppi di ammonio quaternario
US5380522A (en) * 1992-08-11 1995-01-10 Day; Charles E. Method for treatment of irritable bowel syndrome
FI107432B (fi) * 1997-02-06 2001-08-15 Novasso Oy Mikrokiteisen kitosaanin käyttö
CN101239089A (zh) 1997-04-15 2008-08-13 Csir公司 具有食欲抑制剂活性的药物组合物
US5932561A (en) * 1997-10-24 1999-08-03 Rexall Sundown, Inc. Dietary composition with lipid binding properties for weight management and serum lipid reduction
GB2396815B (en) 1999-10-27 2004-09-08 Phytopharm Plc A composition comprising a pregnenone derivative and an NSAID
JP4601100B2 (ja) * 1999-11-08 2010-12-22 三生医薬株式会社 マスティックの油液を内包した軟カプセル
GB2363985B (en) 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
JP4824213B2 (ja) * 2001-07-16 2011-11-30 日本メナード化粧品株式会社 キトサン含有錠剤
KR100679750B1 (ko) * 2005-09-14 2007-02-06 김진만 인체체취저감용 보조식품조성물
ITRM20060204A1 (it) * 2006-04-10 2007-10-11 Vincenzo Savica Farmaci e alimentei per diete normoproteiche iperproteiche ipopro teiche tutte ipofosforiche e bevande ipofosforiche
AU2007330345A1 (en) * 2006-12-07 2008-06-12 Ben-Bar Technology 2006 Mixture and method for reducing cholesterol using hydrophobic chitosan microparticles

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3155575A (en) * 1960-12-16 1964-11-03 Warner Lambert Pharmaceutical Composition for inhibiting pepsin activity and method of preparing same
US3257275A (en) * 1962-02-07 1966-06-21 Weisberg Mark Chitosan containing antacid composition and method of using same
FR3394M (fr) * 1963-07-29 1965-06-28 Jouveinal Lab Médicament a base de saponines obtenues a partir de rhizomes stabilisés de ruscus aculeatus l.
US4223023A (en) * 1978-10-12 1980-09-16 Ivan Furda Nonabsorbable lipid binder
FR2456116A1 (fr) * 1979-05-11 1980-12-05 Sarget Lab Nouvelle saponine triterpenique derivee de la caulophyllogenine et ses applications therapeutiques
DE3040246C2 (de) * 1979-10-29 1985-01-10 Osaka Chemical Laboratory Co., Ltd., Osaka Sojasaponine A↓1↓ und A↓2↓ und ihre Verwendung
US4363801A (en) * 1981-02-09 1982-12-14 The Texas A&M University System Method for treating hyperbilirubinemia
FR2499405A1 (fr) * 1981-02-10 1982-08-13 Biotherm Composition cosmetique amincissante et anti-cellulitique a base d'un extrait de plante contenant des saponines, un extrait d'arnica montana l. et d'un extrait de noix de cola et son procede d'application
JPS5948414A (ja) * 1982-09-10 1984-03-19 Asahi Denka Kogyo Kk ビタミンｅの水溶性製剤
JPS5955895A (ja) * 1982-09-27 1984-03-31 Osaka Chem Lab ソ−ヤサポニン類
JPS5970698A (ja) * 1982-10-14 1984-04-21 Tamura Yakuhin Kogyo Kk 小豆サポニン類の製造方法
US4520017A (en) * 1983-02-04 1985-05-28 Tunc Deger C Method of reducing nutrient absorption

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030056753A (ko) * 2001-12-28 2003-07-04 주식회사 렉스진바이오텍 표고버섯 균사체, 아가리쿠스 균사체, 수용산키토산을함유하는 비만조절용 건강식품조성물

Also Published As

Publication number Publication date
IT8522284A0 (it) 1985-09-26
EP0219156B1 (en) 1990-11-28
DE3675876D1 (de) 1991-01-10
AU596119B2 (en) 1990-04-26
US4999341A (en) 1991-03-12
AU6311386A (en) 1987-04-02
EP0219156A1 (en) 1987-04-22
ATE58639T1 (de) 1990-12-15
JPS62123122A (ja) 1987-06-04
IT1207504B (it) 1989-05-25
CA1273874A (en) 1990-09-11

Similar Documents

Publication Publication Date Title
KR890009376A (ko) 분무 건조된 이부프로펜
KR870002845A (ko) 식욕조절 및 위암억제용 조성물
KR920702216A (ko) 아세틸 d-카르니틴의 녹내장 치료에의 용도
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
DE69940674D1 (de) Orale verabreichung von adenosin analogen
EP0254067A3 (en) Composition for metastasis prevention
KR880010764A (ko) 과콜레스테롤혈중 치료용 혼합물
ATE67677T1 (de) Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten.
ATE311874T1 (de) Kosmetische, diätetische oder pharmazeutische zusammensetzung die thioctsäure und cystein enthalten
KR880004807A (ko) 수산화알루미늄을 함유하는 이부프로펜 조성물
ES2039262T3 (es) Uso de acetil l-carnitina para la preparacion de un medicamento para el tratamiento terapeutico de neuropatias perifericas.
KR850700212A (ko) 서방성 약제학적 캼셀제
EP0130550A3 (de) Auf Schleimhäute des Mundes, der Nase und/oder des Rachens wirkende Arzneimittel auf der Basis von Heparin und Tensiden
KR850700109A (ko) 항 이뇨제 ddavp 및 그의 제조 방법
EP0375628A3 (en) Use of acetyl l-carnitine in the therapeutic treatment of cataract, and pharmaceutical compositions useful in such treatment
KR970061244A (ko) 치매 치료용 약학 조성물
NO20021640L (no) Sammensetning til forebygging og/eller behandling av kretslöpsykdommer som omfatter derivater av L-karnitin ogekstrakter av Gingo biloba
KR880007060A (ko) 제약 조성물
FR2244493A1 (en) Flavonoid amino-acid salts - for treatment of haemorrhage, circulatory disorders and atherosclerosis
CA2067243A1 (en) Compositions and methods for weight reduction
KR920702225A (ko) 약학 조성물
KR870010082A (ko) 구아르(guar) 분말
KR830009776A (ko) 세포 보호 유도방법
KR890015746A (ko) 메게스트롤 아세테이트로 aids 악액질을 치료하는 방법
KR920019356A (ko) 약제학적 조성물 및 그 제조방법

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid